| http://www.w3.org/ns/prov#value | - Further, Schemes 2A and 2B illustrate the details of the individual process steps of the preferred embodiment of the present invention including the culture of the transformed microorganisms in an appropriate fermentation medium through the final step where the purified IFN-?? is stabilized and then lyophilized and reconstituted into therapeutic formulations.
|
